Clinical Trial Update: Study of Azacitidine and Durvalumab in Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating azacitidine with durvalumab in advanced solid tumors has completed enrollment with conditions including microsatellite-stable colorecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer Microsatellite-stable
• Ovarian Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Durvalumab (durvalumab)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Microsatellite Stable Colorectal Carcinoma, Platinum Resistant Epithelial Ovarian Cancer Type II | Phase 2 | Status: COMPLETED